[Combined treatment of cancer of the stomach using a specific immunotherapy].
Autoinoculation is suggested as an adjuvant means to augment the effect of surgery in gastric cancer which may prevent the development of recurrences and metastases. Surgery alone is not a curative method and 5-year survival in gastric cancer stage III ranges from 9.2 to 28%. The data have been obtained on comparative survival in a control group and a group of inoculated patients. The greatest effect was achieved in patients with poorly differentiated adenocarcinoma. Further investigation of the two groups adjusted for the patients' age, kind of surgery and morphological structure of the tumor will help to work out precise criteria for inoculation.
Chissov
V I
VI
Ageenko
A I
AI
Vashakmadze
L A
LA
Babaian
L A
LA
Shcherbitskaia
I Ia
IIa
Drakina
L V
LV
Zubova
Iu E
IuE
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000951:Antigens, Neoplasm / Q000008:administration & dosage* / Q000276:immunology; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D013274:Stomach Neoplasms / Q000276:immunology / Q000473:pathology / Q000601:surgery*
D000951:Antigens, Neoplasm
Combinirovannoe lechenie raka zheludka s ispol'zovaniem spetsificheskoĭmmunoterapii.